Untapped PCOS Market Neuraura is targeting the first effective, over-the-counter device for PCOS treatment, presenting a wide-addressable market with potential for rapid adoption among patients seeking non-prescription options.

Regulatory Pathway Initial launch leverages a predicate regulatory code (NUH) under FDA 510(k), offering a relatively streamlined route to market with potential for expanding claims to insulin resistance and broader PCOS benefits as evidence accumulates.

Future Premium Offering Long-term strategy includes developing a reimbursed, premium device for pre-diabetes and diabetes, signaling opportunities to partner with payers and integrate with existing diabetes care ecosystems.

Clinical & Real-World Validation Planned small-scale clinical studies plus user data collection can create compelling evidence to support expanded indications, enabling cross-sell opportunities into related metabolic conditions.

Emerging Health Tech Stack Primary tech footprint (Wix/WordPress, cloud, eCommerce, and analytics tools) supports rapid digital marketing, direct-to-consumer sales, and scalable customer onboarding, with potential for integration partners in medical device channels.